CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people
Authors
Keywords
-
Journal
Pharmacogenetics and Genomics
Volume 22, Issue 6, Pages 429-440
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-03-16
DOI
10.1097/fpc.0b013e3283527c1c
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk
- (2011) Catherine A. Wassenaar et al. JNCI-Journal of the National Cancer Institute
- Associations of CYP2A6 genotype with smoking behaviors in southern China
- (2010) Tao Liu et al. ADDICTION
- Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended-Duration Transdermal Nicotine Therapy
- (2010) C Lerman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Nicotine Addiction
- (2010) Neal L. Benowitz NEW ENGLAND JOURNAL OF MEDICINE
- Tobacco use among Alaska Native people in the EARTH study
- (2010) J. J. Smith et al. NICOTINE & TOBACCO RESEARCH
- NewCYP2A6gene deletion and conversion variants in a population of Black African descent
- (2010) Jill C Mwenifumbo et al. PHARMACOGENOMICS
- Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism
- (2010) N. Al Koudsi et al. XENOBIOTICA
- Mitochondrial DNA and Y-chromosome variation in five eastern Aleut communities: Evidence for genetic substructure in the Aleut population
- (2009) Mark Zlojutro et al. ANNALS OF HUMAN BIOLOGY
- Nicotine Dependence: Biology, Behavior, and Treatment
- (2009) Riju Ray et al. Annual Review of Medicine
- Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers
- (2009) MK Ho et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment
- (2009) Cristina Rodriguez-Antona et al. HUMAN GENETICS
- Genetic and environmental influences on the ratio of 3′hydroxycotinine to cotinine in plasma and urine
- (2009) Gary E. Swan et al. Pharmacogenetics and Genomics
- A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo
- (2009) Nael Al Koudsi et al. PHARMACOGENOMICS JOURNAL
- Mitochondrial Population Genomics Supports a Single Pre-Clovis Origin with a Coastal Route for the Peopling of the Americas
- (2008) Nelson J.R. Fagundes et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The reality and importance of founder speciation in evolution
- (2008) Alan R. Templeton BIOESSAYS
- Stability of the Nicotine Metabolite Ratio in ad Libitum and Reducing Smokers
- (2008) M. E. Mooney et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Nicotine Metabolism in Three Ethnic/Racial Groups with Different Risks of Lung Cancer
- (2008) K. S. Derby et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Three-Stage Colonization Model for the Peopling of the Americas
- (2008) Andrew Kitchen et al. PLoS One
- The Late Pleistocene Dispersal of Modern Humans in the Americas
- (2008) T. Goebel et al. SCIENCE
- Trans-3′-hydroxycotinine: Disposition kinetics, effects and plasma levels during cigarette smoking
- (2003) N. L. Benowitz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation